Mortality and comorbidity in hospitalized chronic obstructive pulmonary disease patients;Analiza przyczyn zgonów i chorób współistniejących u hospitalizowanych chorych na przewlekłą obturacyjną chorobę płuc

Pneumonologia i Alergologia Polska

Volumn 79, Issue 5, 2011, Pages 343-346

  Rubinsztajn, Renata ^a   Chazan, Ryszarda ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Comorbidity; COPD; Hospitalized patients cause of death

Indexed keywords

EID: 80052049489     PISSN: 08677077     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Światowa strategia rozpoznawania, leczenia i prewencji przewlekłej obturacyjnej choroby płuc. Aktualizacja 2008. Me-dycyna Praktyczna, wydanie specjalne 2009; 6.
2. ATS/ERS Task Force Report: Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur. Respir. J. 2004; 23: 932-946.
3. Sin D.D., Anthonisen N.R., Soriano J.B., Agusti A.G. Mortality in COPD: role of comorbidities. Eur. Respir. J. 2006; 28: 1245-1257.
4. Celli B.R. Predictors of mortality in COPD. Respir. Med. 2010; 104: 773-779.
5. Celli B.R., Cote C.G., Marin J.M. i wsp. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N. Engl. J. Med. 2004; 350: 1005-1012.
6. Barnes P.J., Celli S.F. Systemic manifestations and comorbidi-ties of COPD. Eur. Respir. J. 2009; 33: 1165-1185.
7. Anthonisen N.R., Skeans M.A., Wise R.A., Manfreda J., Kanner R.E., Connett J.E. The effects of smoking cessation intervention on 14.5 year mortality: a randomized clinical trial. Ann. Intern. Med. 2005; 142: 233-239.
8. Sin D., Wu L., Anderson J. i wsp. Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease. Thorax 2005; 60: 992-997.
9. Calverley P.M., Anderson J.A., Celli B. i wsp. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N. Engl. J. Med. 2007; 356: 775-789.
10. Crim C., Calverley P.M., Anderson J.A. i wsp. Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results. Eur. Respir. J. 2009; 34: 641-647.
11. Gudmundsson G., Gislason T., Lindberg E. i wsp. Mortality in COPD patients discharged from hospital: the role of treatment and co-morbidity. Respir. Res. 2006; 7: 109-117.
12. Sethi S. Infection as a comorbidity of COPD. Eur. Respir. J. 2010; 35: 1209-1215.
13. Zielinski J., MacNee W., Wedzicha J. i wsp. Causes of death in patients with COPD and chronic respiratory failure. Monaldi Arch. Chest Dis. 1997; 52: 43-47.